Hereditary factor X deficiency disease
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
: The objective was to examine the genotypic and phenotypic characteristics of individuals with hereditary factor X deficiency (FXD), a rare autosomal recessive bleeding disorder caused by mutations in the F10 gene located on chromosome 13q34-ter.
|
30507709 |
2019 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
: The objective was to examine the genotypic and phenotypic characteristics of individuals with hereditary factor X deficiency (FXD), a rare autosomal recessive bleeding disorder caused by mutations in the F10 gene located on chromosome 13q34-ter.
|
30507709 |
2019 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Genotyping of five Pakistani patients with severe inherited factor X deficiency: identification of two novel mutations.
|
30036279 |
2018 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
BEFREE |
Hereditary factor X (FX) deficiency (FXD) affects 1:500 000-1:1 000 000 people worldwide.
|
29707881 |
2018 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
BEFREE |
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency.
|
29460388 |
2018 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
High-throughput discovery of novel developmental phenotypes.
|
27626380 |
2016 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Molecular defects in the factor X gene caused by novel heterozygous mutations IVS5+1G>A and Asp409del.
|
22931370 |
2013 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X.
|
18036190 |
2008 |
Hereditary factor X deficiency disease
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X.
|
15650540 |
2005 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.
|
10739370 |
2000 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Molecular analysis of the genotype-phenotype relationship in factor X deficiency.
|
10746568 |
2000 |
Hereditary factor X deficiency disease
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
A family with hereditary factor X deficiency with a point mutation Gla32 to Gln in the Gla domain (factor X Tokyo).
|
10468877 |
1999 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.
|
1939653 |
1991 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343.
|
1985698 |
1991 |
Hereditary factor X deficiency disease
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg").
|
1973167 |
1990 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
Molecular characterization of human factor XSan Antonio.
|
2790181 |
1989 |
Hereditary factor X deficiency disease
|
0.360 |
Biomarker
|
disease |
CLINGEN |
The molecular basis of blood coagulation.
|
3286010 |
1988 |